Atlas Trials

Safety, Tolerability and PK of a Single iv Infusion of 10, 40, and 80 µg/kg XG-102 Administered to Healthy Volunteers

Clinical trial NCT01570205 · COMPLETED

Trial details

NCT number
NCT01570205
Sponsor
Xigen SA
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Inflammation
Start date
2011-07-01
Primary completion
2011-11-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.